HCT With PTCy in Higher-risk MDS

Clinical trial NCT06098313 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06098313
Sponsor: Asan Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)

Start date: 2020-07-01
Primary completion: 2027-05-31
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.